title: Cardiotoxicity of doxorubicin: effects of 21-aminosteroids.
abstract: The purposes of this study were to investigate in vivo the effects of two lazaroids,U-74389G (21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-pregna-1,4,9 (11)-triene-3,20-dione (2)-2-butenenedionate) and U-83836E (-)-2-[[4-(2,6-di-1-pyrrlidinyl-4-pyrimidinyl)-1-piperazinyl]methy l]-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-ol, dihydrochloride against the cardiotoxicity induced by doxorubicin in rat and the mechanisms underlying such a toxicity. Doxorubicin (DXR) administered intraperitoneally (5 mg/kg 4 times per week for 1 week) induced significant decrease of body weight, ECG alterations and 100% mortality. The lazaroids used in this study did not protect from DXR-induced cardiotoxicity. Our results showed that the compound U-74389G delayed, but did not reduce DXR-induced mortality, and did not prevent body weight loss and ECG changes. The compound U-83836E was unable to modify any toxic effects induced by DXR. These data indicate that oxygen free radicals and the subsequent increase in intracellular calcium are only steps of DXR progressive general toxicity that leads to cardiac injury. In conclusion, we propose that the 21-aminosteroids, potent inhibitors of membrane lipid peroxidation, alone are not enough to protect from DXR toxic effects.
authors.affiliation: Institute of Pharmacology and Toxicology, Faculty of Medicine and Surgery 2nd University of Naples, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Falcone
authors.forename: W
authors.initials: W
authors.lastname: Filippelli
authors.forename: B
authors.initials: B
authors.lastname: Mazzarella
authors.forename: R
authors.initials: R
authors.lastname: Tufano
authors.forename: P
authors.initials: P
authors.lastname: Mastronardi
authors.forename: A
authors.initials: A
authors.lastname: Filippelli
authors.forename: L
authors.initials: L
authors.lastname: Berrino
authors.forename: F
authors.initials: F
authors.lastname: Rossi
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D000975:Antioxidants / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D002839:Chromans / Q000494:pharmacology*; D004317:Doxorubicin / Q000633:toxicity*; D004562:Electrocardiography / Q000187:drug effects; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000139:chemically induced / Q000401:mortality / Q000517:prevention & control*; D008297:Male; D010879:Piperazines / Q000494:pharmacology*; D011281:Pregnatrienes / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; D000975:Antioxidants; D002839:Chromans; D010879:Piperazines; D011281:Pregnatrienes; C074965:U 74389F; C066382:U 78517F; D004317:Doxorubicin